Molecular and immunohistochemical analysis of ERBB2 expression in correlation with proliferation rate in synovial sarcoma

Diagnostic Molecular Pathology

Volumn 16, Issue 4, 2007, Pages 211-217

  Krsková, Lenka ^a,b   Kalinová, Marketa ^a   Břizová, Helena ^a   Mrhalová, Marcela ^a   Sumerauer, David ^a   Kodet, Roman ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ERBB2; FISH; Immunohistochemistry; Ki 67; Real time RT PCR; Synovial sarcoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; RECEPTOR, ERBB-2; RNA, MESSENGER; SARCOMA, SYNOVIAL;

EID: 36649030427     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3180621995     Document Type: Article

References (30)

1. Turc-Carel C, Dal Cin P, Limon J, et al. Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A. 1987;84:1981-1985.
2. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994;7:502-508.
3. de Leeuw B, Balemans M, Olde Weghuis D, et al. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18) (p11.2;q11.2)- positive synovial sarcomas. Hum Mol Genet. 1995;4:1097-1099.
4. Allander SV, Illei PB, Chen Y, et al. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol. 2002;161:1587-1595.
5. Kato H, Tjernberg A, Zhang W, et al. SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. 1. J Biol Chem. 2002;277:5498-5505.
6. Nagai M, Tanaka S, Tsuda M, et al. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc Natl Acad Sci U S A. 2001;98:3843-3848.
7. Nilsson G, Skytting B, Xie Y, et al. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res. 1999;59:3180-3184.
8. Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer. 2001;37(suppl 4):S3-S8.
9. Press MF, Pike MC, Chazin VR, et al. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res. 1993;53:4960-4970.
10. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177-182.
11. Muss HB, Thor AD, Berry DA, et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med. 1994;330:1260-1266.
12. George E, Niehans GA, Swanson PE, et al. Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation. Arch Pathol Lab Med. 1992;116:1033-1035.
13. Inagaki H, Murase T, Otsuka T, et al. Detection of SYT-SSX fusion transcript in synovial sarcoma using archival cytologic specimens. Am J Clin Pathol. 1999;111:528-533.
14. Bijwaard KE, Aguilera NS, Monczak Y, et al. Quantitative realtime reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem. 2001;47:195-201.
15. Anninga JK, van de Vijver MJ, Cleton-Jansen AM, et al. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas. Eur J Cancer. 2004;40:963-970.
16. dos Santos NR, de Bruijn DR, Balemans M, et al. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. Hum Mol Genet. 1997;6:1549-1558.
17. Thomas DG, Giordano TJ, Sanders D, et al. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma. Cancer. 2005;103:830-838.
18. Barbashina V, Benevenia J, Aviv H, et al. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases. J Cancer Res Clin Oncol. 2002;128:610-616.
19. Somers GR, Ho M, Zielenska M, et al. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study. Pediatr Dev Pathol. 2005;8:525-532.
20. Park HR, Kim YW, Jung WW, et al. Evaluation of HER-2/neu status by real-time quantitative PCR in malignant cartilaginous tumors. Int J Oncol. 2004;24:575-580.
21. Kim GY, Park JH, Kim YW, et al. Absence of amplification of HER-2/neu (c-erbB-2) gene in Ewing's sarcoma: a real-time polymerase chain reaction method. Pathol Res Pract. 2004;200:663-667.
22. Hall PA, Hughes CM, Staddon SL, et al. The c-erb B-2 protooncogene in human pancreatic cancer. J Pathol. 1990;161:195-200.
23. Hantschmann P, Jeschke U, Friese K. TGF-alpha, c-erbB-2 expression and neoangiogenesis in vulvar squamous cell carcinoma. Anticancer Res. 2005;25:1731-1737.
24. Coombs LM, Pigott DA, Sweeney E, et al. Amplification and overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br J Cancer. 1991;63:601-608.
25. Sugg SL, Ezzat S, Zheng L, et al. Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia. Clin Endocrinol. 1998;49:629-637.
26. Soares P, Sambade C, Sobrinho-Simoes M. Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid. Int J Cancer. 1994;56:459-461.
27. Sapi Z, Papai Z, Hruska A, et al. Her-2 oncogene amplification, chromosome 17 and DNA ploidy status in synovial sarcoma. Pathol Oncol Res. 2005;11:133-138.
28. Nuciforo PG, Pellegrini C, Fasani R, et al. Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma. Hum Pathol. 2003;34:639-645.
29. Antonescu CR, Leung DH, Dudas M, et al. Alterations of cell cycle regulators in localized synovial sarcoma: a multifactorial study with prognostic implications. Am J Pathol. 2000;156:977-983.
30. Lopes JM, Nesland JM, Reis-Filho JS, et al. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin. Histopathology. 2002;40:464-471.